Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avricore Health (AVCRF) Short-term Investments (2016 - 2022)

Avricore Health has reported Short-term Investments over the past 9 years, most recently at $237691.3 for Q3 2022.

  • Quarterly Short-term Investments fell 3.48% to $237691.3 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $237691.3 through Sep 2022, down 3.48% year-over-year, with the annual reading at $247366.2 for FY2021, 3213.77% up from the prior year.
  • Short-term Investments was $237691.3 for Q3 2022 at Avricore Health, down from $243145.6 in the prior quarter.
  • Over five years, Short-term Investments peaked at $252193.4 in Q2 2021 and troughed at $7212.0 in Q2 2020.
  • The 5-year median for Short-term Investments is $12836.8 (2018), against an average of $110813.7.
  • Year-over-year, Short-term Investments crashed 43.06% in 2020 and then soared 3396.84% in 2021.
  • A 5-year view of Short-term Investments shows it stood at $12840.1 in 2018, then decreased by 1.35% to $12667.0 in 2019, then plummeted by 39.44% to $7670.5 in 2020, then surged by 3106.21% to $245934.2 in 2021, then fell by 3.35% to $237691.3 in 2022.
  • Per Business Quant, the three most recent readings for AVCRF's Short-term Investments are $237691.3 (Q3 2022), $243145.6 (Q2 2022), and $244737.4 (Q1 2022).